MarketLens

Pricing Plans Sign Up Log in

Pro Investment Ideas

Why Biotech Just Had Its Best Week in Years—And Why This Rally Could Be Different

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Intel Just Had Its Best Day in Years—And Apple Might Be the Reason Why

3 months ago

The Cannabis Sector Just Had Its Wildest Week Ever. Here's What Smart Investors Should Know.

2 months ago

The AI Memory Gold Rush: Why This Chip Shortage Is Different—And How to Profit From It

3 months ago

Why Did Bitcoin Just Have Its Worst Q1 in Eight Years

2 weeks ago

Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up

BridgeBio stock popped Tuesday after a notable shake-up occurred in the patent battle concerning Pfizer's rival drug, tafamidis.

PFE

Stock News•1 week ago

Here's Why USA Rare Earth Shares Surged This Week

USA Rare Earth shares surged this week following management's 2030 targets, which highlight the Round Top deposit's unique high heavy rare earth content.

USAR

News•1 week ago

Record Highs In Small Caps - Durable Rally Or Short-Term Bounce?

Small-cap indexes reached record highs recently, prompting investor debate over whether this marks a durable rally or a temporary short-term bounce.

Stock News•2 months ago

Here's Why Biotech ETFs Are Rallying Hard

Biotech ETFs, including IBB, XBI, CANC, and IDNA, neared one-year highs following a market rally. The gains are attributed to improving valuations, expectations for rate cuts, and positive FDA outcome...

IBB